Cosmos Health Inc. (COSM)
NASDAQ: COSM · Real-Time Price · USD
0.4700
-0.0219 (-4.45%)
At close: Jan 29, 2026, 4:00 PM EST
0.4877
+0.0177 (3.77%)
After-hours: Jan 29, 2026, 6:36 PM EST
Cosmos Health Revenue
Cosmos Health had revenue of $17.11M in the quarter ending September 30, 2025, with 37.86% growth. This brings the company's revenue in the last twelve months to $59.79M, up 6.69% year-over-year. In the year 2024, Cosmos Health had annual revenue of $54.43M with 1.97% growth.
Revenue (ttm)
$59.79M
Revenue Growth
+6.69%
P/S Ratio
0.22
Revenue / Employee
$401,294
Employees
149
Market Cap
16.41M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 54.43M | 1.05M | 1.97% |
| Dec 31, 2023 | 53.38M | 3.03M | 6.02% |
| Dec 31, 2022 | 50.35M | -5.89M | -10.48% |
| Dec 31, 2021 | 56.24M | 833.33K | 1.50% |
| Dec 31, 2020 | 55.41M | 15.73M | 39.65% |
| Dec 31, 2019 | 39.68M | 2.59M | 6.99% |
| Dec 31, 2018 | 37.08M | 7.07M | 23.56% |
| Dec 31, 2017 | 30.01M | 23.26M | 344.28% |
| Dec 31, 2016 | 6.76M | 6.22M | 1,165.53% |
| Dec 31, 2015 | 533.80K | -7.11M | -93.01% |
| Dec 31, 2014 | 7.64M | 6.74M | 746.55% |
| Dec 31, 2013 | 902.37K | - | - |
| Dec 31, 2012 | - | - | - |
| Jul 31, 2009 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| McKesson | 387.09B |
| Cencora | 321.33B |
| Cardinal Health | 234.31B |
| Henry Schein | 12.94B |
| Accendra Health | 10.77B |
| 111, Inc. | 1.91B |
| Quipt Home Medical | 245.36M |
| EDAP TMS | 74.85M |
COSM News
- 9 days ago - Cosmos Health Announces Accelerating Customer Growth, Improving Unit Economics and Robotic Expansion Supporting $40M in Additional Annual Revenue - GlobeNewsWire
- 15 days ago - Cosmos Health Announces Initiation of Analyst Coverage with $4.50 Valuation by Zacks Small-Cap Research - GlobeNewsWire
- 24 days ago - Cosmos Health Enters Manufacturing Agreement with Libytec for PathMuscle Medicine, with Five-Year Volumes Expected to Exceed 1.2 Million Units - GlobeNewsWire
- 5 weeks ago - Cosmos Health Is Building a Platform, and Tariffs Are Accelerating the Strategy - Accesswire
- 5 weeks ago - Cosmos Health is Forcing the Market to Reframe the Conversation - Accesswire
- 2 months ago - Cosmos Health Launches Strategic Partnership With Prime Ledger to Transform $300M Treasury and Tokenize IP Assets - GlobeNewsWire
- 2 months ago - Cosmos Health CEO Greg Siokas Adds 3,398,055 Shares Year-to-Date 2025 Following Continued November Purchases - GlobeNewsWire
- 2 months ago - Cosmos Health Reports Record Q3 2025 Results with All-Time High Revenue, Gross Profit and Gross Margin; Revenue Up 38% to $17.1M, Gross Profit Up 116% to $2.6M, Adjusted EBITDA Up 74%, Cash Position Up to $4.63M from $0.66M - GlobeNewsWire